PureTech and Seaport Report Positive GlyphAgo Phase 1 Data
BOSTON, June 8, 2026 PureTech Health and its Founded Entity Seaport Therapeutics announced positive results from the multiple-ascending dose...
GlyphAgo
Advertisement
Advertisement
